CareDx (CDNA) Competitors $14.78 -0.10 (-0.64%) As of 02:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CDNA vs. CON, SGRY, PRVA, HTFL, VCYT, CELC, LFST, ADUS, PGNY, and ARDTShould you be buying CareDx stock or one of its competitors? The main competitors of CareDx include Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), Heartflow (HTFL), Veracyte (VCYT), Celcuity (CELC), LifeStance Health Group (LFST), Addus HomeCare (ADUS), Progyny (PGNY), and Ardent Health (ARDT). These companies are all part of the "healthcare" industry. CareDx vs. Its Competitors Concentra Group Holdings Parent Surgery Partners Privia Health Group Heartflow Veracyte Celcuity LifeStance Health Group Addus HomeCare Progyny Ardent Health CareDx (NASDAQ:CDNA) and Concentra Group Holdings Parent (NYSE:CON) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings. Is CDNA or CON more profitable? CareDx has a net margin of 17.97% compared to Concentra Group Holdings Parent's net margin of 7.44%. Concentra Group Holdings Parent's return on equity of 50.84% beat CareDx's return on equity.Company Net Margins Return on Equity Return on Assets CareDx17.97% 18.03% 12.88% Concentra Group Holdings Parent 7.44%50.84%5.89% Does the media prefer CDNA or CON? In the previous week, CareDx had 2 more articles in the media than Concentra Group Holdings Parent. MarketBeat recorded 5 mentions for CareDx and 3 mentions for Concentra Group Holdings Parent. CareDx's average media sentiment score of 0.85 beat Concentra Group Holdings Parent's score of 0.48 indicating that CareDx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareDx 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Concentra Group Holdings Parent 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate CDNA or CON? CareDx currently has a consensus price target of $25.50, indicating a potential upside of 72.59%. Concentra Group Holdings Parent has a consensus price target of $27.75, indicating a potential upside of 33.35%. Given CareDx's higher probable upside, research analysts clearly believe CareDx is more favorable than Concentra Group Holdings Parent.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CareDx 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57Concentra Group Holdings Parent 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, CDNA or CON? CareDx has a beta of 2.28, suggesting that its stock price is 128% more volatile than the S&P 500. Comparatively, Concentra Group Holdings Parent has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Which has stronger earnings and valuation, CDNA or CON? Concentra Group Holdings Parent has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCareDx$333.79M2.36$52.55M$1.0214.49Concentra Group Holdings Parent$1.90B1.40$166.54M$1.1917.49 SummaryCareDx beats Concentra Group Holdings Parent on 7 of the 13 factors compared between the two stocks. Get CareDx News Delivered to You Automatically Sign up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDNA vs. The Competition Export to ExcelMetricCareDxMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$787.70M$7.57B$5.66B$10.35BDividend YieldN/A2.77%5.75%4.64%P/E Ratio14.5171.7076.2226.09Price / Sales2.3638.92559.23125.64Price / Cash11.0822.3637.6061.24Price / Book2.096.7612.376.33Net Income$52.55M$245.04M$3.29B$270.93M7 Day Performance1.27%-1.34%1.07%0.17%1 Month Performance15.34%0.52%3.59%6.15%1 Year Performance-50.44%10.33%60.72%28.28% CareDx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDNACareDx4.084 of 5 stars$14.78-0.6%$25.50+72.6%-48.5%$787.70M$333.79M14.51740Analyst ForecastCONConcentra Group Holdings Parent3.0568 of 5 stars$21.26-4.0%$27.50+29.3%-10.5%$2.84B$1.90B18.0111,250Positive NewsSGRYSurgery Partners2.9455 of 5 stars$21.60-1.2%$33.00+52.8%-33.1%$2.80B$3.11B-15.1015,000PRVAPrivia Health Group4.2483 of 5 stars$22.34-2.0%$28.58+27.9%+33.2%$2.80B$1.74B203.111,140Trending NewsAnalyst ForecastAnalyst RevisionHTFLHeartflowN/A$32.89-1.5%$35.80+8.8%N/A$2.71BN/A0.00699Earnings ReportVCYTVeracyte3.6787 of 5 stars$31.87+3.2%$40.90+28.3%-1.6%$2.43B$445.76M96.58790CELCCelcuity1.7555 of 5 stars$55.07+0.3%$56.50+2.6%+262.0%$2.33BN/A-15.9640LFSTLifeStance Health Group3.3328 of 5 stars$5.18-1.0%$8.50+64.1%-23.9%$2.03B$1.25B-103.6010,218ADUSAddus HomeCare4.9621 of 5 stars$109.27-0.9%$138.89+27.1%-13.2%$2.03B$1.15B24.1249,703Positive NewsPGNYProgyny3.9086 of 5 stars$22.13-1.7%$25.30+14.3%+28.3%$1.94B$1.17B37.51310Positive NewsARDTArdent Health3.2414 of 5 stars$12.65-3.3%$19.33+52.8%-31.7%$1.87B$5.97B7.2324,900 Related Companies and Tools Related Companies Concentra Group Holdings Parent Alternatives Surgery Partners Alternatives Privia Health Group Alternatives Heartflow Alternatives Veracyte Alternatives Celcuity Alternatives LifeStance Health Group Alternatives Addus HomeCare Alternatives Progyny Alternatives Ardent Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDNA) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CareDx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CareDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
